Some price data may be temporarily unavailable.
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Abiomed Return vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Abiomed Company Info
Abiomed is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.
News & Analysis
Why Abiomed Stock Skyrocketed Today
A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion.
Why Shares of Abiomed Rose 18.4% in July
The company's stock rose steadily throughout the month.
2 Hot Stocks to Buy and Hold Until You Retire
They have strong products and high financial performance.
Abiomed to Shareholders: Patience Please, Growth Is On The Way.
Despite record revenue for its latest quarter, the medical device maker's shares sank 8% following its earnings release. But its next stage of growth is coming.
Buy These 3 Breakout Healthcare Stocks if There's a Sell-Off or Correction
I've been waiting to buy these stocks at a better price. Now might just be the time.
This Company Will Fix the Hidden COVID Danger to Come
There are long-term implications to the coronavirus pandemic that the market is not appreciating.
Could Abiomed Be a Millionaire-Maker Stock?
This medical device company has revenue growth, patents, and a bright outlook.
Here's the Surprising Coronavirus Stock You'll Really Want to Own
It's not a vaccine company, a drugmaker, or a diagnostics company.
2 Winners and 2 Losers in the Med Tech Market This Quarter
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
3 Medical Device Companies for Your Watchlist
Recurring revenue, monopolistic market positions, and returns that tend to beat even the risky biotechs tie these three together.
The Top Healthcare Stocks of 2018: Can They Continue in 2019?
These healthcare stocks crushed the S&P 500's return last year, but that doesn't guarantee they'll be top performers in 2019.
ABIOMED, inc (ABMD) Q2 2022 Earnings Call Transcript
ABMD earnings call for the period ending September 30, 2021.
ABIOMED, inc (ABMD) Q1 2022 Earnings Call Transcript
ABMD earnings call for the period ending June 30, 2021.
Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript
ABMD earnings call for the period ending March 31, 2021.
Abiomed Inc (ABMD) Q3 2021 Earnings Call Transcript
ABMD earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.